☰

Patricia D. Kroboth - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Pharmacology, Pharmacy, Pharmaceutical Chemistry
Tree Info Similar researchers PubMed Report error

55 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Poloyac SM, Empey KM, Rohan LC, Skledar SJ, Empey PE, Nolin TD, Bies RR, Gibbs RB, Folan M, Kroboth PD. Core competencies for research training in the clinical pharmaceutical sciences. American Journal of Pharmaceutical Education. 75: 27. PMID 21519417 DOI: 10.5688/Ajpe75227  0.503
2009 Bigos KL, Folan MM, Jones MR, Haas GL, Kroboth FJ, Kroboth PD. Dysregulation of neurosteroids in obsessive compulsive disorder. Journal of Psychiatric Research. 43: 442-5. PMID 18514738 DOI: 10.1016/J.Jpsychires.2008.04.007  0.772
2006 Fabian TJ, Schwartzman DS, Ujhelyi MR, Corey SE, Bigos KL, Pollock BG, Kroboth PD. Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam. Journal of Cardiovascular Electrophysiology. 17: 391-5. PMID 16643361 DOI: 10.1111/J.1540-8167.2006.00416.X  0.742
2004 Riechman SE, Fabian TJ, Kroboth PD, Ferrell RE. Steroid sulfatase gene variation and DHEA responsiveness to resistance exercise in MERET. Physiological Genomics. 17: 300-6. PMID 15152080 DOI: 10.1152/Physiolgenomics.00097.2003  0.318
2004 Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Corey SE, Begley AE, Bensasi SG, Weber E, Dew MA, Reynolds CF, Pollock BG. Paroxetine-induced hyponatremia in older adults: a 12-week prospective study. Archives of Internal Medicine. 164: 327-32. PMID 14769630 DOI: 10.1001/Archinte.164.3.327  0.445
2003 Fabian TJ, Amico JA, Kroboth PD, Mulsant BH, Reynolds CF, Pollock BG. Paroxetine-induced hyponatremia in the elderly due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Journal of Geriatric Psychiatry and Neurology. 16: 160-4. PMID 12967059 DOI: 10.1177/0891988703255689  0.494
2003 Kroboth PD, Amico JA, Stone RA, Folan M, Frye RF, Kroboth FJ, Bigos KL, Fabian TJ, Linares AM, Pollock BG, Hakala C. Influence of DHEA administration on 24-hour cortisol concentrations. Journal of Clinical Psychopharmacology. 23: 96-9. PMID 12544381 DOI: 10.1097/00004714-200302000-00014  0.782
2002 Bies RR, Gastonguay MR, Coley KC, Kroboth PD, Pollock BG. Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 10: 696-705. PMID 12427578 DOI: 10.1097/00019442-200211000-00008  0.61
2002 Salek FS, Bigos KL, Kroboth PD. The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies. Journal of Clinical Pharmacology. 42: 247-66. PMID 11865961 DOI: 10.1177/00912700222011274  0.728
2001 Fabian TJ, Dew MA, Pollock BG, Reynolds CF, Mulsant BH, Butters MA, Zmuda MD, Linares AM, Trottini M, Kroboth PD. Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults. Biological Psychiatry. 50: 767-74. PMID 11720695 DOI: 10.1016/S0006-3223(01)01198-2  0.503
2001 Folan MM, Stone RA, Pittenger AL, Stoffel JA, Hess MM, Kroboth PD. Dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol concentrations in intensive care unit patients. Critical Care Medicine. 29: 965-70. PMID 11378605 DOI: 10.1097/00003246-200105000-00012  0.747
2000 Frye RF, Kroboth PD, Kroboth FJ, Stone RA, Folan M, Salek FS, Pollock BG, Linares AM, Hakala C. Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults. Journal of Clinical Pharmacology. 40: 596-605. PMID 10868310  0.32
2000 Bonate PL, Kroboth PD, Smith RB, Suarez E, Oo C. Clonazepam and sertraline: absence of drug interaction in a multiple-dose study. Journal of Clinical Psychopharmacology. 20: 19-27. PMID 10653204 DOI: 10.1097/00004714-200002000-00005  0.449
2000 Fabian T, Kroboth P, Folan M, Kroboth F, Sweeney J, Corey S, Duggal M, Amico J. 478. Saccadic eye movement responses to DHEA & alprazolam in patients with adrenal insuffiency Biological Psychiatry. 47: S146. DOI: 10.1016/S0006-3223(00)00748-4  0.784
2000 Erosheva E, Salek F, Stone R, Folan M, Greenhouse J, Kroboth P. 477. Characterizing the diurnal rhythm of DHEA and effects of an oral dose of alprazolam Biological Psychiatry. 47: S145. DOI: 10.1016/S0006-3223(00)00747-2  0.77
2000 Frye RF, Kroboth PD, Kroboth FJ, Stone RA, Folan M, Salek FS, Pollock BG, Linares AM, Hakala C. Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults. The Journal of Clinical Pharmacology. 40: 596-605. DOI: 10.1002/J.1552-4604.2000.Tb05985.X  0.562
1999 Kroboth PD, Salek FS, Stone RA, Bertz RJ, Kroboth FJ. Alprazolam increases dehydroepiandrosterone concentrations. Journal of Clinical Psychopharmacology. 19: 114-24. PMID 10211912 DOI: 10.1097/00004714-199904000-00005  0.432
1999 Kroboth PD, Salek FS, Pittenger AL, Fabian TJ, Frye RF. DHEA and DHEA-S: a review. Journal of Clinical Pharmacology. 39: 327-48. PMID 10197292 DOI: 10.1177/00912709922007903  0.328
1999 Fabian TJ, Kroboth PD, Butters MA, Linares AM, Zmuda M, Mulsant B, Pollock B. ARE DHEA AND/OR DHEA-S CONCENTRATIONS ASSOCIATED WITH REMISSION OF DEPRESSION OR IMPROVEMENTS IN MENTAL STATUS SCORES IN OLDER ADULTS? The American Journal of Geriatric Psychiatry. 7: 46-47. DOI: 10.1097/00019442-199911001-00136  0.43
1998 Kroboth PD, Folan MM, Bauer KS, Tullock W, Wright CE, Sweeney JA. Do alprazolam-induced changes in saccadic eye movement and psychomotor function follow the same time course? Journal of Clinical Pharmacology. 38: 337-46. PMID 9590461 DOI: 10.1002/J.1552-4604.1998.Tb04433.X  0.767
1997 Kroboth PD, McAuley JW. Progesterone: does it affect response to drug? Psychopharmacology Bulletin. 33: 297-301. PMID 9230647  0.315
1996 McAuley JW, Kroboth FJ, Kroboth PD. Oral administration of micronized progesterone: a review and more experience. Pharmacotherapy. 16: 453-7. PMID 8726605 DOI: 10.1002/J.1875-9114.1996.Tb02977.X  0.424
1995 Kroboth PD, Folan MM, Lush RM, Chaikin PC, Shukla UA, Barbhaiya R, Salazar DE. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment. Journal of Clinical Psychopharmacology. 15: 306-19. PMID 8830061 DOI: 10.1097/00004714-199510000-00002  0.793
1995 Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH. Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepam. Journal of Clinical Psychopharmacology. 15: 409-16. PMID 8748429 DOI: 10.1097/00004714-199512000-00004  0.444
1995 McAuley JW, Reynolds IJ, Kroboth FJ, Smith RB, Kroboth PD. Orally administered progesterone enhances sensitivity to triazolam in postmenopausal women. Journal of Clinical Psychopharmacology. 15: 3-11. PMID 7714225 DOI: 10.1097/00004714-199502000-00002  0.368
1995 Derry CL, Kroboth PD, Pittenger AL, Kroboth FJ, Corey SE, Smith RB. Pharmacokinetics and pharmacodynamics of triazolam after two intermittent doses in obese and normal-weight men Journal of Clinical Psychopharmacology. 15: 197-205. PMID 7635997 DOI: 10.1097/00004714-199506000-00008  0.337
1995 Kroboth PD, McAuley JW, Derry CL. Time-dependent sensitization to triazolam? An observation in three studies. Journal of Clinical Psychopharmacology. 15: 192-6. PMID 7635996 DOI: 10.1097/00004714-199506000-00007  0.483
1995 Kroboth PD, McAuley JW, Kroboth FJ, Bertz RJ, Smith RB. Triazolam pharmacokinetics after intravenous, oral, and sublingual administration. Journal of Clinical Psychopharmacology. 15: 259-62. PMID 7593708 DOI: 10.1097/00004714-199508000-00004  0.449
1993 Kroboth PD, Bertz RJ, Smith RB. Acute tolerance to triazolam during continuous and step infusions: estimation of the effect offset rate constant. The Journal of Pharmacology and Experimental Therapeutics. 264: 1047-55. PMID 8450449  0.335
1993 Smith RB, Kroboth PD, Folan MM, Kroboth FJ, Rosanske TW. Design and pharmacodynamic evaluation of novel dual release formulations of triazolam. International Journal of Clinical Pharmacology, Therapy, and Toxicology. 31: 422-9. PMID 8225690  0.786
1992 Schmith VD, Piraino B, Smith RB, Kroboth PD. Alprazolam in end-stage renal disease. II. Pharmacodynamics. Clinical Pharmacology and Therapeutics. 51: 533-40. PMID 1587068 DOI: 10.1038/Clpt.1992.59  0.458
1991 Kroboth PD, Maxwell RA, Fleishaker JC, Van Thiel DH, Smith RB. Comparison of adinazolam pharmacokinetics and effects in healthy and cirrhotic subjects. Journal of Clinical Pharmacology. 31: 580-6. PMID 1880225 DOI: 10.1002/J.1552-4604.1991.Tb03741.X  0.434
1991 Schmith VD, Piraino B, Smith RB, Kroboth PD. Alprazolam in end-stage renal disease: I. Pharmacokinetics. Journal of Clinical Pharmacology. 31: 571-9. PMID 1880224 DOI: 10.1002/J.1552-4604.1991.Tb03740.X  0.401
1990 Kroboth PD, McAuley JW, Smith RB. Alprazolam in the elderly: pharmacokinetics and pharmacodynamics during multiple dosing. Psychopharmacology. 100: 477-84. PMID 2320708 DOI: 10.1007/Bf02243999  0.466
1989 Garzone PD, Kroboth PD. Pharmacokinetics of the newer benzodiazepines. Clinical Pharmacokinetics. 16: 337-64. PMID 2567646 DOI: 10.2165/00003088-198916060-00002  0.367
1988 Kroboth PD, Smith RB, Erb RJ. Tolerance to alprazolam after intravenous bolus and continuous infusion: Psychomotor and EEG effects Clinical Pharmacology and Therapeutics. 43: 270-277. PMID 3345619 DOI: 10.1038/Clpt.1988.32  0.416
1987 Smith RB, Kroboth PD, Juhl RP. The clinical pharmacist in drug research and development. An academic-industrial center. Drug Intelligence & Clinical Pharmacy. 21: 127-9. PMID 3816573 DOI: 10.1177/10600280870211P213  0.647
1987 Juhl RP, Kroboth PD. Conceptual issues in designing a clinical scientist program. Drug Intelligence & Clinical Pharmacy. 21: 103-6. PMID 3816565 DOI: 10.1177/10600280870211P205  0.636
1987 Kroboth PD, Smith RB, Van Thiel DH, Juhl RP. Nighttime dosing of triazolam in patients with liver disease and normal subjects: kinetics and daytime effects. Journal of Clinical Pharmacology. 27: 555-60. PMID 3655006 DOI: 10.1002/J.1552-4604.1987.Tb03066.X  0.74
1987 Smith RB, Kroboth PD, Varner PD. Pharmacodynamics of Triazolam After Intravenous Administration The Journal of Clinical Pharmacology. 27: 971-979. PMID 3437069 DOI: 10.1002/J.1552-4604.1987.Tb05599.X  0.463
1987 Silver MR, Kroboth PD. Pentoxifylline in end-stage renal disease. Drug Intelligence & Clinical Pharmacy. 21: 976-8. PMID 3428162 DOI: 10.1177/106002808702101209  0.381
1987 Smith RB, Kroboth PD. Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects. Psychopharmacology. 93: 105-112. PMID 3114808 DOI: 10.1007/Bf02439595  0.45
1986 Smith RB, Kroboth PD, Phillips JP. Temporal Variation in Triazolam Pharmacokinetics and Pharmacodynamics After Oral Administration The Journal of Clinical Pharmacology. 26: 120-124. PMID 3950055 DOI: 10.1002/J.1552-4604.1986.Tb02919.X  0.476
1985 Kroboth PD, Smith RB, Stoehr GP, Juhl RP. Pharmacodynamic evaluation of the benzodiazepine-oral contraceptive interaction. Clinical Pharmacology and Therapeutics. 38: 525-32. PMID 2865026 DOI: 10.1038/Clpt.1985.218  0.716
1985 Kroboth PD, Smith RB, Silver MR, Rault R, Sorkin MI, Puschett JB, Juhl RP. Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics. British Journal of Clinical Pharmacology. 19: 839-42. PMID 2862896 DOI: 10.1111/J.1365-2125.1985.Tb02725.X  0.728
1985 Kroboth PD, Smith RB, Rault R, Silver MR, Sorkin MI, Puschett JB, Juhl RP. Effects of end-stage renal disease and aluminum hydroxide on temazepam kinetics. Clinical Pharmacology and Therapeutics. 37: 453-9. PMID 2858279 DOI: 10.1038/Clpt.1985.70  0.738
1984 Greenberg A, Piraino BH, Kroboth PD, Weiss J. Severe theophylline toxicity. Role of conservative measures, antiarrhythmic agents, and charcoal hemoperfusion. The American Journal of Medicine. 76: 854-860. PMID 6720731 DOI: 10.1016/0002-9343(84)90997-5  0.336
1984 Smith RB, Kroboth PD, Vanderlugt JT, Phillips JP, Juhl RP. Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration. Psychopharmacology. 84: 452-6. PMID 6152055 DOI: 10.1007/Bf00431449  0.731
1984 Juhl RP, Daugherty VM, Kroboth PD. Incidence of next-day anterograde amnesia caused by flurazepam hydrochloride and triazolam. Clinical Pharmacy. 3: 622-5. PMID 6150782 DOI: 10.1093/Ajhp/41.12.2690  0.691
1984 Stoehr GP, Kroboth PD, Juhl RP, Wender DB, Phillips JP, Smith RB. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics. Clinical Pharmacology and Therapeutics. 36: 683-90. PMID 6149030 DOI: 10.1038/Clpt.1984.240  0.727
1984 Kroboth PD, Smith RB, Sorkin MI, Silver MR, Rault R, Garry M, Juhl RP. Triazolam protein binding and correlation with alpha-1 acid glycoprotein concentration. Clinical Pharmacology and Therapeutics. 36: 379-83. PMID 6147221 DOI: 10.1038/Clpt.1984.191  0.697
1984 Kroboth PD. Hearing Loss and Erythromycin Pharmacokinetics in Patients Receiving Hemodialysis-Reply Jama Internal Medicine. 144: 420-420. DOI: 10.1001/Archinte.1984.00350140253047  0.362
1983 Kroboth PD, Juhl RP. New drug evaluations. Triazolam. Drug Intelligence & Clinical Pharmacy. 17: 495-500. PMID 6135590 DOI: 10.1177/106002808301700701  0.678
1983 Kroboth PD, McNeil MA, Kreeger A, Dominguez J, Rault R. Hearing Loss and Erythromycin Pharmacokinetics in a Patient Receiving Hemodialysis Jama Internal Medicine. 143: 1263-1265. DOI: 10.1001/Archinte.1983.00350060195035  0.352
1982 Kroboth PD, Brown A, Lyon JA, Kroboth FJ, Juhl RP. Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjects. Antimicrobial Agents and Chemotherapy. 21: 135-40. PMID 7081971 DOI: 10.1128/Aac.21.1.135  0.722
Show low-probability matches.